Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Clancy

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Emerging Themes in Epidemiology|December 5, 2017
Flexible semiparametric joint modeling: an application to estimate individual lung function decline and risk of pulmonary exacerbations in cystic fibrosisDan Li, Ruth Keogh, John P Clancy, et al.
Stat (International Statistical Institute)|March 30, 2018
Joint hierarchical Gaussian process model with application to personalized prediction in medical monitoringLeo L Duan, Xia Wang, John P Clancy, et al.
Journal of Healthcare Engineering|June 7, 2021
An Animated Functional Data Analysis Interface to Cluster Rapid Lung Function Decline and Enhance Center-Level Care in Cystic FibrosisJesse Pratt, Weiji Su, Don Hayes, et al.
Respiratory Research|August 11, 2023
CFTR dysfunction in smooth muscle drives TGFβ dependent airway hyperreactivityElizabeth L Kramer, Kristin M Hudock, Cynthia R Davidson, et al.
Pharmacogenetics and Genomics|December 17, 2014
PharmGKB summary: very important pharmacogene information for CFTREllen M McDonagh, John P Clancy, Russ B Altman, et al.
The European Respiratory Journal|March 23, 2018
Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosisCormac McCarthy, John J Brewington, Beth Harkness, et al.
... Health Innovations and Point-Of-Care Technologies Conference. Health Innovations and Point-Of-Care Technologies Conference|March 30, 2018
Early Detection of Rapid Cystic Fibrosis Disease Progression Tailored to Point of Care: A Proof-of-Principle StudyRhonda Szczesniak, Cole Brokamp, Weiji Su, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 8, 2018
Subacute TGFβ expression drives inflammation, goblet cell hyperplasia, and pulmonary function abnormalities in mice with effects dependent on CFTR functionElizabeth L Kramer, William D Hardie, Satish K Madala, et al.
American Journal of Respiratory Cell and Molecular Biology|April 26, 2003
Adenosine receptors and phosphodiesterase inhibitors stimulate Cl- secretion in Calu-3 cellsBryan R Cobb, Lijuan Fan, Timea E Kovacs, et al.
Pediatric Pulmonology|December 19, 2015
Predicting future lung function decline in cystic fibrosis patients: Statistical methods and clinical connectionsRhonda D Szczesniak, Gary L McPhail, Dan Li, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Emerging Themes in Epidemiology|December 5, 2017
Flexible semiparametric joint modeling: an application to estimate individual lung function decline and risk of pulmonary exacerbations in cystic fibrosisDan Li, Ruth Keogh, John P Clancy, et al.
Stat (International Statistical Institute)|March 30, 2018
Joint hierarchical Gaussian process model with application to personalized prediction in medical monitoringLeo L Duan, Xia Wang, John P Clancy, et al.
Journal of Healthcare Engineering|June 7, 2021
An Animated Functional Data Analysis Interface to Cluster Rapid Lung Function Decline and Enhance Center-Level Care in Cystic FibrosisJesse Pratt, Weiji Su, Don Hayes, et al.
Respiratory Research|August 11, 2023
CFTR dysfunction in smooth muscle drives TGFβ dependent airway hyperreactivityElizabeth L Kramer, Kristin M Hudock, Cynthia R Davidson, et al.
Pharmacogenetics and Genomics|December 17, 2014
PharmGKB summary: very important pharmacogene information for CFTREllen M McDonagh, John P Clancy, Russ B Altman, et al.
The European Respiratory Journal|March 23, 2018
Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosisCormac McCarthy, John J Brewington, Beth Harkness, et al.
... Health Innovations and Point-Of-Care Technologies Conference. Health Innovations and Point-Of-Care Technologies Conference|March 30, 2018
Early Detection of Rapid Cystic Fibrosis Disease Progression Tailored to Point of Care: A Proof-of-Principle StudyRhonda Szczesniak, Cole Brokamp, Weiji Su, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 8, 2018
Subacute TGFβ expression drives inflammation, goblet cell hyperplasia, and pulmonary function abnormalities in mice with effects dependent on CFTR functionElizabeth L Kramer, William D Hardie, Satish K Madala, et al.
American Journal of Respiratory Cell and Molecular Biology|April 26, 2003
Adenosine receptors and phosphodiesterase inhibitors stimulate Cl- secretion in Calu-3 cellsBryan R Cobb, Lijuan Fan, Timea E Kovacs, et al.
Pediatric Pulmonology|December 19, 2015
Predicting future lung function decline in cystic fibrosis patients: Statistical methods and clinical connectionsRhonda D Szczesniak, Gary L McPhail, Dan Li, et al.
Pageof 13